The controversial drug, Seroquel, will have additional application to treat depression in adults if the drug maker AstraZeneca receives approval from the FDA. Seroquel use has been linked to diabetes, and two serious complications known as Neuroleptic Malignant Syndrome and Tardive Dyskinesia.